Jyong Biotech Ltd. (MENS)
NASDAQ: MENS · Real-Time Price · USD
2.120
+0.040 (1.92%)
At close: Sep 15, 2026, 4:00 PM EDT
2.130
+0.010 (0.47%)
After-hours: Sep 15, 2026, 5:41 PM EDT
Jyong Biotech Market Cap
Jyong Biotech has a market cap or net worth of $157.37 million as of September 15, 2026. Its market cap has decreased by -96.67% in one year.
Market Cap
157.37M
Enterprise Value
174.75M
1-Year Change
-96.67%
Ranking
Category
Stock Price
$2.12
ChartMarket Cap Chart
Since June 17, 2025, Jyong Biotech's market cap has decreased from $777.46M to $157.37M, a decrease of -79.76%. That is a compound annual growth rate of -72.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 157.37M | -48.19% |
| Dec 31, 2025 | 303.76M | -60.93% |
| Jun 17, 2025 | 777.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Humacyte | 157.68M |
| Corbus Pharmaceuticals Holdings | 157.05M |
| Molecular Partners AG | 156.35M |
| Immunic | 155.82M |
| Spruce Biosciences | 154.33M |
| Kazia Therapeutics | 153.34M |
| Unicycive Therapeutics | 147.35M |
| NRx Pharmaceuticals | 147.09M |